Amgen | AMGN - Market Capitalization


Amgen reported $203.95B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
ALKERMES USD 5.65B 696M Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Coherus Biosciences USD 278M 184M Jun/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
Exelixis USD 12.27B 523M Feb/2026
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 300.37B 39.11B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Takeda JPY 7.64T 774.9B Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026